tirzepatide vs semaglutide effectiveness comparison efficacy of versus in achieving therapeutic targets in type 2 diabetes: a post hoc analysis of the SURPASS-2 Trial Semaglutide vs Tirzepatide: Is Tirzepatide

Within six months, seven out of the 10 were able to stop taking insulin altogether, according to the report

The implementation of this non-invasive tool may help reduce risks to patients and potentially prevent unnecessary surgical cancellations in GLP-1RA users

mays (Table 1)

4 A large 2025 scoping review identified hair loss as an "emerging" adverse effect worth systematic investigation, noting that most existing studies lack formal dermatologic diagnostic confirmation, meaning real-world prevalence is likely underreported

It has a short half-life and works well in cycles or in combination with other GH-releasing peptides